Bosch Packaging Technology to buy machinery business from Eisai

Published: 9-Feb-2012
Packaging Finance

Broadening its inspection technology equipment portfolio

Bosch Packaging Technology of Germany is to acquire the machinery business of Eisai Co, a leading Japanese pharmaceutical company based in Tokyo, to broaden its inspection technology equipment portfolio.

The Eisai machinery business specialises in inspection machinery for the pharmaceutical industry and in 2010 generated sales of around €76m (JPY8.6bn) with 120 associates worldwide.

The business has facilities and service centres in Japan, Germany, US and China.

All financial details about the transaction remain confidential. The deal is subject to compliance with antitrust legislation.

‘Eisai and Bosch have been cooperating for years. We have formed a close partnership with Eisai, both with its pharmaceutical business and its subsidiary Eisai Machinery, which markets Bosch machines in Japan,’ said Friedbert Klefenz, president of Bosch Packaging Technology.

Eisai’s inspection technology is used in liquid pharmaceuticals with ampoules, pre-filled syringes, infusion bottles or vials, as well as in the production of solid pharmaceuticals such as tablets.

In addition, the Eisai machinery companies sell pharmaceutical packaging materials and machines from various manufacturers.

Klefenz says the acquisition will enable Bosch to offer a broader product portfolio in the area of inspection technology, from basic inspection solutions to fully automated high-performance systems for all commonly used applications on the market.

‘We can see excellent growth opportunities,’ he said. ‘Inspection technology is of prime importance to pharmaceutical manufacturers, because of rising demands on the production and packaging process due to increasing levels of safety requirements worldwide. With this acquisition, we will also further increase our presence in the Japanese market.’

In addition, Bosch intends to continue growing Eisai’s pharmaceutical packaging machines and materials business.

  • Companies:
  • Bosch
  • Eisai
See more

You may also like

Finance

Eisai and Fuji Yakuhin sign ASEAN distribution agreement for gout therapy

Read more
Hyperuricemia is known to be associated with various diseases in the urinary system, endocrine system, metabolic system, cardio-cerebrovascular system etc., including gout

Trending Articles

  1. Dual-chamber packaging systems as a simplification factor in the supply chain Dual-chamber packaging solutions could represent a new frontier also to package parenteral drugs, simplifying the supply chain through reconstitution, potentially making logistics more flexible and efficient, says Cecilia Bassi, Product Manager at Bormioli Pharma
  2. Ascend Advanced Therapies expands US footprint through Advanced BioScience Laboratories merger Ascend's collaboration with EW Healthcare partners will expand its reach in the US pharmaceutical market through capital investment and an uptick in GMP AAV manufacturing capacity
  3. Syncona launches early-stage drug development company, Slingshot Therapeutics The novel early-stage pharmaceutical company aims to collaborate with academic institutions to bring their findings to the clinic, with their first programme centring around inflammatory disease
  4. Bormioli Pharma to digitise package leaflets using augmented reality The project is part of the Bormioli Pharma Invents innovation programme, which aims to provide concrete answers to some of the most important challenges in the pharmaceutical packaging sector.
  5. Merck attains $588m global license for PD-1/VEGF bispecific antibody from LaNova Medicines The bispecific antibody is designed for oncological indications and functions by inhibiting the PD-1/PD-L1 and the VEGF/VEGFR receptor signalling pathways

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

You may also like

Finance

Eisai and Fuji Yakuhin sign ASEAN distribution agreement for gout therapy

Hyperuricemia is known to be associated with various diseases in the urinary system, endocrine system, metabolic system, cardio-cerebrovascular system etc., including gout
Packaging

Bosch Packaging Technology becomes Syntegon

The business will focus on intelligent and sustainable technologies and the service offering will also be expanded
Manufacturing

Parsolex and Bosch partner to share solid dose technologies

The strategic partnership will allow CDMO Parsolex access to Bosch pharma tech and Bosch access to a manufacturing site in the US
Packaging

Insulin cartridges inspection: Technology puts safety and quality first

Insulin producers need sophisticated filling technology and advanced inspection systems to adhere to the stringently high safety and quality standards and protect the product and patients. Andreas Gross of Bosch Packaging Technology, explains</p>
Packaging

Bosch sells Packaging Machinery business to private equity firm

Luxemburg-based CVC Capital Partners has purchased the business but the pharma and food units will remain intact
Manufacturing

Filling and closing machine from Bosch honoured with Red Dot Award

Expert jury acknowledges functionality and machine design
Packaging

Bosch to sell food and pharma packaging business

Equipment manufacturer plans to sell packaging technology division, which generated €1.3 billion in sales last year
Subscribe now